DrugPatentWatch Database Preview

Patent: 6,147,279

« Back to Dashboard

Summary for Patent: 6,147,279

Title:	Inhibition of gene expression
Abstract:	A method of inhibiting gene expression is described. The method, which affects enzymatic activity in a plant. The method includes expressing in a plant, or a cell, a tissue or an organ thereof, a nucleotide sequence wherein the nucleotide sequence codes, partially or completely, for an intron in an antisense orientation; and wherein the nucleotide sequence does not contain a sequence that is antisense to an axon sequence normally associated with the intron.
Inventor(s):	Poulsen; Peter (Copenhagen, DK)
Assignee:	Danisco A/S (Copenhagen, DK)
Application Number:	08/981,803
Patent Claims:	see list of patent claims

Details for Patent 6,147,279

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Schering	INTRON A	interferon alfa-2b	VIAL	103132	003	1986-06-04		Danisco A/S (Copenhagen, DK)	2015-07-14	RX		search
Schering	INTRON A	interferon alfa-2b	VIAL	103132	002	1986-06-04		Danisco A/S (Copenhagen, DK)	2015-07-14	RX		search
Schering	INTRON A	interferon alfa-2b	VIAL	103132	001	1986-06-04		Danisco A/S (Copenhagen, DK)	2015-07-14	RX		search

International Patent Family for US Patent 6,147,279

Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	9704112
New Zealand	313626
Mexico	9800500
Japan	H11509103